Skip to main content
Clinical Trials/NCT05345457
NCT05345457
Recruiting
Phase 4

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

University Hospitals Cleveland Medical Center3 sites in 1 country88 target enrollmentJanuary 13, 2023

Overview

Phase
Phase 4
Intervention
Azithromycin Pill
Conditions
Pregnancy Preterm
Sponsor
University Hospitals Cleveland Medical Center
Enrollment
88
Locations
3
Primary Endpoint
Delivery within 28 days
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

A randomized, controlled, non-placebo trial to primarily assess the effect of oral, outpatient antibiotics (i.e., azithromycin and amoxicillin) on latency (i.e., proportion of patients that deliver within 28 days from membrane rupture) following previable, prelabor rupture of membranes between 18 0/7 and 22 6/7 weeks gestational age.

Registry
clinicaltrials.gov
Start Date
January 13, 2023
End Date
June 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Hackney MD, MS

Division Director, Maternal-Fetal Medicine

University Hospitals Cleveland Medical Center

Eligibility Criteria

Inclusion Criteria

  • English-speaking
  • Live, singleton gestation
  • Patient able to provide informed consent
  • Gestational age between 18 weeks and 0 days and 22 weeks and 6 days at the time of -membrane rupture
  • Diagnosis of preterm, prelabor rupture of membranes by clinical exam findings of either 1) visualization of amniotic fluid passing from the cervical canal and/or pooling in the vagina via sterile speculum examination, 2) a basic pH (i.e., positive nitrazine) test of vaginal fluid, 3) arborization (i.e., ferning) of dried vaginal fluid identified via microscopic examination, and/or 4) an amniotic fluid index (AFI) of less than 4cm

Exclusion Criteria

  • Gestational dating performed or confirmed by ultrasound at ≥ 18 weeks and 0 days gestational age
  • Patient desires pregnancy interruption or induction of labor
  • Known major fetal anomaly or aneuploidy
  • Amniocentesis ≤ 7 days of diagnosis of rupture of membranes
  • Cervical cerclage placement ≤ 7 days of diagnosis of rupture of membranes
  • Known drug allergy or significant adverse reactions to macrolide or penicillin antibiotics
  • Current antibiotic use at the time of membrane rupture diagnosis
  • Vaginal bleeding at the time of membrane rupture diagnosis or within first 24 hours from diagnosis
  • Febrile at the time of membrane rupture diagnosis (i.e., temperature ≥ 38 degrees Celsius) and/or within first 24 hours of diagnosis
  • Active preterm labor at the time of membrane rupture diagnosis (i.e., consistent contraction pattern associated with cervical change) and/or within first 24 hours of diagnosis

Arms & Interventions

Antibiotics

Patients randomized into the treatment (i.e., antibiotics) arm of the study will be treated with a seven-day course of oral azithromycin and amoxicillin. Azithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days). Amoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home.

Intervention: Azithromycin Pill

Antibiotics

Patients randomized into the treatment (i.e., antibiotics) arm of the study will be treated with a seven-day course of oral azithromycin and amoxicillin. Azithromycin will be dosed as single 500 mg dose (2-250mg oral tablets) administered immediately following randomization, yet prior to discharge to home, followed with 1-250mg oral tablet daily for 4 additional days (for a total of 5 days). Amoxicillin will be dosed as a single-500mg oral tablet three times daily for 7 days with first dose also being given prior to discharge home.

Intervention: Amoxicillin Pill

Outcomes

Primary Outcomes

Delivery within 28 days

Time Frame: 28 days from date of rupture

The proportion of patients that undergo a spontaneous or medically-indicated delivery within 28 days from diagnosis of previable prelabor rupture of membranes (pPPROM)

Secondary Outcomes

  • Severe neonatal morbidity composite(From date of delivery to date of hospital discharge (up to 6 months))
  • Severe maternal morbidity composite(From diagnosis of membrane rupture to 6 weeks following delivery)

Study Sites (3)

Loading locations...

Similar Trials